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AbstrAct
Patients undergoing surgery are at increased risk of 
acute kidney injury (AKI). AKI is associated with adverse 
outcomes such as increased mortality and future risk of 
developing chronic kidney disease. We have developed a 
validated preoperative scoring tool to predict postoperative 
AKI in patients undergoing orthopaedic surgery using 
seven readily available parameters. The aim of this project 
was to establish the use of this scoring tool with a target 
compliance of 80% in patients undergoing orthopaedic 
surgery requiring an overnight stay at Perth Royal 
Infirmary, a district general hospital in NHS Tayside. We 
created an intervention bundle for patients at high risk of 
AKI, which we defined as greater than 10%. An electronic 
tool available on smartphones and desktop computers 
was developed that can be used to calculate the score. 
The interventions were incorporated into the electronic 
tool and posters outlining the intervention were placed 
in clinical areas. Patients undergoing elective procedures 
were scored in the preassessment clinic while emergency 
patients were scored by the admitting doctors. The score 
was introduced using four PDSA cycles. This confirmed 
that the scoring tool functioned well and was being used 
accurately. Compliance for patients undergoing elective 
surgery was reasonable at 19/24 (79%) in the third 
and fourth PDSA cycles but was poorer for emergency 
admissions with compliance of only 3/7 (43%). There 
was excellent compliance with the suggested medication 
changes and postoperative blood test monitoring as 
advised by our intervention bundle for those at high risk of 
AKI. Fluid balance monitoring was advised for all patients 
but the outcome was similar following our intervention at 
27/41 (66%) compared with 23/37 (62%) in the baseline 
data collection. Compliance with fluid balance monitoring 
was higher in patients at high risk of AKI (9/12, 75%).
Problem
Acute kidney injury (AKI) is an abrupt (hours 
to days) decrease in renal function. Patients 
undergoing surgery are at risk of developing 
an AKI postoperatively with significantly 
increased morbidity and mortality. Preven-
tion of AKI is particularly important as no 
specific treatment, other than supportive 
care, is available.
In 2015, we published a preoperative 
scoring tool designed for patients undergoing 
orthopaedic surgery that predicted the risk of 
developing postoperative AKI.1 The tool uses 
seven predictors that are readily available; 
age, gender, presence or absence of diabetes, 
estimated glomerular filtration rate (eGFR), 
American Society of Anaesthesiologists (ASA) 
grade, use of ACE inhibitors or angiotensin 
receptor blockers (ARBs) and the number of 
prescribed medications. This allows identifi-
cation of patients who are at high risk of AKI.
NHS Tayside is a Scottish health board which 
covers a population of 415 000 and carries out 
approximately 4000 orthopaedic operations 
per year across three sites. The Perth Royal 
Infirmary carries out approximately 1100 of 
these operations, of which 50% are elective. 
It has two orthopaedic wards; an elective 
ward and an emergency/trauma ward. Elec-
tronic alerts for AKI are active on both wards 
and use changes in creatinine to detect AKI 
according to the Kidney Disease Improving 
Global Outcomes criteria.2
We aimed to introduce the use of the AKI 
prediction score into the preoperative assess-
ment of patients undergoing orthopaedic 
surgery in the Perth Royal Infirmary aiming 
for 80% compliance, alongside an interven-
tion bundle for those identified as high risk. 
The intervention bundle included guidance 
on perioperative fluid management, with-
holding certain medications associated with 
an increased risk of AKI at the time of surgery 
and on monitoring renal function postoper-
atively (see online supplementary appendix 
1). We introduced the tool simultaneously 
into the preassessment clinics for patients 
undergoing elective surgery and the ortho-
paedic wards for patients requiring emer-
gency surgery.
background
AKI is common postoperatively though 
reported rates vary depending on the type 
of surgery. Rates of AKI in our population 
are between 7% and 11% for patients under-
going orthopaedic surgery.1
Evidence shows that even mild episodes 
of AKI are associated with an increased risk 
of death1 3 4 and of progression to chronic 
kidney disease in the long term.5 In addition, 
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patients who develop AKI spend an average of 4.7 days 
more in hospital and it is estimated that it costs the 
National Heath Service (NHS) between £434 million and 
£620 million per year.6
There are a number of scoring tools available that 
predict AKI in a range of settings.7–9 The scoring tool we 
used was specifically developed and validated for use in 
patients undergoing orthopaedic surgery.
The cause of AKI in the perioperative setting is often 
multifactorial but there are several interventions with the 
potential to reduce risk.10 Certain commonly prescribed 
medications are well established in the cause of AKI11 
particularly in the context of an acute insult such as 
hypotension or volume depletion. These include ACE 
inhibitors, ARBs, non-steroidal anti-inflammatory drugs 
(NSAIDs) and diuretics. We therefore advised that these 
medicines were withheld perioperatively in those patients 
at high risk of AKI. Hypovolaemia and hypotension are 
also important causes of AKI in the perioperative period 
and so we advised careful fluid balance monitoring 
and the prescribing of intravenous fluids if required 
postoperatively.
Delays in the diagnosis of AKI are associated with 
poorer outcome.12 We included postoperative moni-
toring of renal function as part of our intervention for 
those at high risk of AKI.
baseline measuremenT
The ultimate goal of introducing the preoperative AKI 
prediction scoring tool was to reduce the rate and severity 
of AKI in patients undergoing orthopaedic surgery 
at the Perth Royal Infirmary. The power required to 
generate a clinically and statistically significant result, 
however, was beyond the scope of this project.
We carried out a baseline audit of current practice by 
retrospectively reviewing the notes of all patients who had 
orthopaedic surgery between 6 June 2016 and 19 June 
2016. Data were obtained for 37 patients and the infor-
mation we obtained informed our interventions.
The first objective of this project was to introduce the 
AKI scoring tool into the preoperative assessment of 
patients undergoing orthopaedic surgery using an elec-
tronic tool that was available on desktop computers and 
smartphones and to assess if it was reliable and easy to 
use. At the time of the baseline audit, the AKI scoring 
tool had not been implemented and so patients were not 
being risk-stratified.
For patients found to be at high risk of AKI, which 
we defined as preoperative risk of AKI of greater than 
10%, we created a bundle of three interventions aimed 
at reducing the incidence and/or severity of AKI. We 
chose a relatively low threshold as the cut-off for high risk 
based on the simplicity and minimal risk of harm of the 
proposed interventions as well as the number of patients 
affected based on our previous work. Our second objec-
tive was to alter the management of patients at high risk 
of AKI according to our intervention bundle.
The first intervention was aimed at ensuring patients 
were kept well hydrated by keeping an accurate fluid 
balance perioperatively and considering intravenous 
fluids if the patient’s oral intake was poor or there were 
any signs of dehydration/hypovolaemia. There was 
also additional information in the bundle as to when 
to consider urgent fluid resuscitation. Our measures 
included whether adequate fluid balance monitoring 
covering intake and output was in place and if patients 
who developed hypotension were reviewed. In the base-
line audit, only 23/37 (62%) of patients had adequate 
fluid balance monitoring postoperatively. Intravenous 
fluids were prescribed in 16/37 (43%) patients and 10/17 
(59%) patients were considered high risk for AKI using 
the scoring tool. Postoperative hypotension (defined 
as systolic blood pressure(BP) <100 mm Hg) occurred 
in nine (24%) patients. Of these, eight patients had 
intravenous fluid administered but there were only two 
cases where the hypotension prompted a documented 
review. Of note, we did not recommend that all patients 
at high risk of AKI be given intravenous fluid routinely 
postoperatively.
Consideration was also given as to whether patients at 
high risk should be catheterised routinely. Due to the risk 
of catheter-related infection, we did not include routine 
catheterisation of high-risk patients.
Our second intervention related to withholding certain 
medications around the time of surgery. The perioper-
ative drug management guideline in place prior to this 
project stipulated patients on ACE inhibitors or ARBs 
should have these medications withheld on the day of 
surgery and that patients on NSAIDs should stop these 3 
days before surgery. It also stated that aldosterone antago-
nists should be withheld on the day of surgery but not did 
comment on loop or thiazide diuretics.
In the baseline audit, six patients were on an ACE 
inhibitor or ARB. All six patients had these medications 
withheld on the day of surgery though it was restarted 
on day 1 postoperatively in four patients. Of note, four 
of the patients who had their ACE inhibitors or ARBs 
restarted postoperatively required further doses to be 
withheld during their admission due to low BP, which 
suggested that restarting these medications routinely 
on day 1 postoperatively was premature. We recom-
mended that patients at high risk of AKI withhold these 
medicines on the day of surgery and day 1 and day 2 
postoperatively.
With regards to NSAIDs, 4/37 patients were on regular 
NSAIDs preoperatively. Only one of these patients did 
not have their NSAIDs withheld preoperatively. This was 
a patient undergoing palliation for metastatic cancer. 
NSAIDs were started for postoperative pain in three 
patients (all low risk). Our intervention bundle did not 
alter the advice to withhold the NSAIDs from 3 days 
preoperatively but added that they should be used with 
caution postoperatively for those at high risk of AKI.
No patients in the baseline audit were on loop or thia-
zide diuretics; one patient was on spironolactone and 
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this was withheld on the day of surgery. Our interven-
tion bundle advised that all diuretics should be withheld 
routinely on the day of surgery and that fluid balance 
should be monitored closely when restarting these medi-
cations postoperatively. It was agreed that the anaesthetist 
would make this decision based on the individual patient.
In the baseline audit, 7/37 patients did not have post-
operative bloods checked, including one patient who 
would have been considered at high risk of AKI using 
the scoring tool. In our intervention bundle, we advised 
that all patients should have their bloods checked on day 
1 and day 3 postoperatively (or on day 2 if they were to 
be discharged that day) with further monitoring of renal 
function if the patient develops an AKI. This was based 
on a separate project in the orthopaedic unit, which 
reviewed the results of six patients over the age of 75 years 
who developed an AKI. This found that checking bloods 
only on day 1 postoperatively would have missed AKI in 
five out of six cases.
We planned to collect data by reviewing the notes of 
all patients discharged on selected days and assessing 
compliance with our intervention.
design
Our first objective was that at least 80% of patients under-
going orthopaedic surgery at the Perth Royal Infirmary 
(excluding day cases) had their AKI risk calculated using 
the risk score we previously developed.1 Our first step 
was to incorporate the score into a platform that would 
be easily accessible for everyone. Using the free plat-
form  calcapp. net we created an electronic tool which 
functioned as an app on smartphone or tablet (iOS or 
android) or as a web page on a computer. The calculator 
could be opened on a tablet browser with a link or saved 
to the desktop to function as an app. Saving it allowed it 
to be used offline. This allowed easy access for staff. We 
ensured that it was available on a desktop in case staff 
did not have access to a smartphone or found it easier to 
use on a computer. We anticipated that many of the staff 
using the score would not have prior experience calcu-
lating ASA grades and so we included clear guidelines on 
how to grade patients adapted from the American Associ-
ation of Anaesthesiology website into our electronic tool.
The calcapp platform13 is a web platform to allow the 
building and hosting of calculator apps without the need 
for specialist coding experience. It uses the same inputs 
and formulae as a spreadsheet. The lack of specialist 
coding knowledge was beneficial as our team had limited 
prior experience in app design and coding.
We implemented our change in practice for emergency 
and elective patients simultaneously as the interventions 
were the same in both groups.
A renal consultant, renal registrar and three anaes-
thetists with an interest in orthopaedic surgery and AKI 
were closely involved in designing the intervention. 
This included planning the baseline audit and using the 
information gathered from it to create the intervention 
bundle. Our team also included three Foundation Year 2 
(FY2)s; one developed the electronic tool and the other 
two were involved in data collection.
Prior to implementing the intervention, we consulted 
various teams and individuals whose support would be 
crucial to the success of the project. This included the 
orthopaedic consultants and senior trainees, the wider 
anaesthetic team and the junior doctors on the ortho-
paedic wards. We also met with the charge nurses of the 
orthopaedic wards who disseminated our plan to the 
ward nurses.
A poster was created with the intervention bundle 
along with advice on how to carry out a fluid review and 
when to consider urgent fluid resuscitation. The poster 
contained a QR code which linked to the electronic 
tool. Posters were placed in the orthopaedic wards and 
in the preassessment clinic. The intervention bundle was 
also available by accessing the electronic tool. The ward 
clerk in the preassessment unit ensured that there was an 
adequate supply of high risk of AKI stickers in the preas-
sessment unit and on both orthopaedic wards.
All elective patients are seen in the preassessment 
clinic by preassessment nurses and have their bloods 
checked. We met with the preassessment nurses before 
implementing the intervention to get their feedback and 
ensure they knew how to use the scoring tool. Our plan 
was that patients would have their AKI score completed in 
the preassessment clinic and documented in the medical 
notes. Patients who are high risk would get a red sticker 
added to the front of their notes stating ‘High risk of 
AKI’. This would be seen by the secretaries who would 
add a note to the operating theatre list flagging that the 
patient was at high risk of AKI. As the score requires a 
patient's eGFR, it cannot be done until the following day. 
While this could potentially cause problems as patients 
may need to be contacted after the clinic, it would only 
affect patients on loop or thiazide diuretics and the preas-
sessment nurses did not think this would significantly add 
to their workload. The admitting junior doctor would 
then be responsible for making the postoperative medi-
cation changes and ensuring bloods are checked postop-
eratively. The stickers highlighting those patients at high 
risk would also be visible to the nursing staff reinforcing 
the need for accurate fluid balance monitoring postop-
eratively (though this would be expected in all patients).
Emergency patients are admitted directly from Acci-
dent & Emergency and are clerked by the junior doctors. 
For these patients the clerking doctors would have respon-
sibility for completing the score, putting the sticker and 
intervention bundle in the notes if indicated, and making 
any medication adjustments. Again, the ward staff would 
be responsible for the remainder of interventions.
sTraTegy
We used Plan, Do, Stay, Act (PDSA) cycles to achieve 
our first objective which was that at least 80% of patients 
undergoing orthopaedic surgery requiring an overnight 
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stay would have their AKI risk calculated using the scoring 
tool (see table 1).
PDSA cycle 1 aimed to assess if the scoring tool was func-
tional, reliable and being completed accurately. The staff 
in the preassessment clinic and on the orthopaedic wards 
were advised to start using the AKI risk score and inter-
vention bundle. Data were collected covering admissions 
between 29 June 2017 and 18 July 2017 and focused on 
whether the score was being completed accurately. Only 
four patients were identified in our sampling; data were 
also collected on day case and non-operative patients but 
as the score is not intended for use in these patients they 
were excluded. Three out of four patients had the score 
completed but unfortunately it was done incorrectly on 
two occasions (both on emergency patients). This was 
most likely due to the incorrect ASA grade being used in 
both cases. Verbal feedback from staff confirmed that the 
electronic tool was reliable and functioning well.
In the second PDSA cycle, we aimed to improve the 
accuracy of scoring. This cycle coincided with a change in 
the junior doctors on the wards; a face-to-face education 
session was held with the new doctors, which covered the 
rationale for the intervention and their role. The guid-
ance from the American Society of Anaesthesiology on 
ASA grading included in the scoring tool, was highlighted 
to them. This cycle collected data covering admissions 
between 12 August 2017 and 31 August 2017. Data were 
collected on six patients; unfortunately, only two of these 
patients had the score completed (both accurate). This 
may have been related to the fact that the new doctors 
starting on the ward had a lot of new processes to adapt 
to and did not prioritise completing the score.
The main aim of the third PDSA cycle was to 
boost compliance with completing the score. Verbal 
reminders were given to the doctors at the trauma 
meeting (attended by all senior and junior orthopaedic 
staff). This included a practical demonstration on 
completing the score and explanation of the rationale 
behind the intervention bundle. Data were collected 
covering admissions between 1 September 2017 and 
28 September 2017. Reassuringly there was a significant 
boost in compliance with the score being carried out in 
10 out of 13 patients who had their notes assessed. This 
was largely driven by elective patients with 9 out of 10 
elective patients having the score complete compared 
with only 1 out of 3 emergency patients. The score was 
accurate in 9 out of 10 cases.
The fourth PDSA cycle covered patients admitted 
between 2 October 2017 and 28 October 2017 with the 
focus in this cycle being to improve compliance with 
completing the score and to collect a larger sample 
of data to assess how well the intervention bundle 
was being adhered to in high-risk patients. Prelimi-
nary results were presented at the departmental audit 
meeting and ongoing verbal encouragement was given 
to medical staff. Twelve out of 18 patients in this cycle 
had the score completed (10/14 elective patients and 
2/4 emergency patients). The score was accurate in all 
cases. Eight of the patients were high risk, all of whom 
had stickers appropriately placed on the front of their 
notes. A full induction is planned for the new doctors in 
the next rotation and a rolling departmental audit will 
continue.
Table 1 PDSA cycles
PDSA cycle 1 2 3 4
Aim Establish reliability of 
scoring tool and accuracy 
completing the AKI risk 
score
Improve accuracy 
completing the AKI risk 
score
Improve compliance with 
completing the AKI risk 
score
Assess compliance with 
intervention bundle
Intervention AKI risk score introduced 
with electronic tool for 
calculating it on desktop 
and mobile devices 
available along with an 
intervention bundle for 
patients at high risk of AKI
Coincided with junior 
doctor change-over. 
Face-to-face education 
session with new 
doctors, highlighted 
guidance in scoring 
tool on ASA grading 
to ensure accuracy 
completing the score
Junior and senior 
orthopaedic staff briefed 
at daily trauma meeting 
with demonstration of 
scoring and explanation 
of bundle rationale
Collect data on larger 
sample. Presentation 
of preliminary results at 
department audit meeting 
and ongoing verbal 
encouragement given to 
junior staff
Number of patients 
in data collection
4 6 13 18
Outcome Three of four patients had 
score completed, correct 
in only one patient. Errors 
due to incorrect ASA 
grade being used
Drop in compliance 
completing the score 




10/13 patients scored 
having score complete; 
9 of those scored were 
accurate
12/18 patients scored. 
All scores accurate and 
stickers applied to all high-
risk notes
AKI, acute kidney injury; ASA, American Society of Anaesthesiologists.
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resulTs
In total, the score was completed in 27/41 (66%) patients 
who had their notes reviewed. There were relatively small 
numbers in the first and second PDSA cycles but there was 
a drop in compliance in the second PDSA cycle that we 
think is at least partly attributable to new doctors starting 
on the ward (it was the first rotation for the Foundation 
Year 1 (FY1 doctors). Overall compliance improved again 
following this (see figure 1).
There was a higher rate of compliance with the AKI 
scoring tool in elective patients; the combined results 
from the third and fourth PDSA cycles found the rate of 
compliance with the score was just below target at 19/24 
(79%). The corresponding result for emergency patients 
was disappointingly lower at three of seven (43%). Of 
note; for patients undergoing either hip or knee surgery 
the compliance was better at 25/32 (78%) compared with 
2/9 (22%) for patients undergoing upper limb or foot 
surgery.
The accuracy of using the tool significantly improve-
ment as the project progressed and was 100% by the 
fourth PDSA cycle.
We also collected data to assess compliance with the 
intervention bundle. Twelve of the patients who had their 
score calculated were classified as high-risk; there was 
100% compliance with using the high-risk of AKI stickers 
for these patients. We calculated the scores retrospectively 
for patients who did not have them done preoperatively; 
4/14 would have been classified as high-risk.
Fluid balance monitoring covering intake and output 
was adequate in 9/12 (75%) of those patients classified as 
high-risk. Reassuringly, our intervention did not adversely 
impact those patients classified as low-risk where a similar 
rate (11/15, 73%) had adequate fluid balance moni-
toring. We did observe however poorer monitoring in 
those with no score done where only 7/14 (50%) had 
adequate fluid balance monitoring. The lower rate in the 
latter group may be in part due to a higher proportion of 
patients undergoing upper limb or foot surgery (7/14) as 
ward staff may not prioritise these patients for close moni-
toring postoperatively. The overall rate of adequate fluid 
balance monitoring was 27/41 (66%), very similar to the 
62% in the baseline audit.
Five patients developed postoperative hypoten-
sion (systolic BP <100 mm Hg); only one patient was 
reviewed and given intravenous fluid (they had been 
scored as low-risk). We advised that hypotension in any 
patient should prompt a medical review and intravenous 
fluid should be considered. This has not demonstrably 
changed practice.
With regard to medication changes for patients at high 
risk of AKI; seven patients were on an ACE inhibitor or 
ARB and six were on diuretics. All were withheld appro-
priately. The preoperative advice regarding NSAIDs was 
the same in all patients regardless of AKI risk. Three 
patients classified as being at high risk of AKI were on 
NSAIDs preoperatively; they were withheld in two of 
them. Similarly, two of three patients found to be at low 
risk of AKI and two of four patients who did not get the 
score done had their NSAIDs withheld preoperatively. 
Two of 12 patients at high risk of AKI were given NSAIDs 
postoperatively for pain management.
Bloods were checked as per our intervention bundle 
(ie, at least twice postoperatively) in all patients found to 
be at high risk of AKI. Bloods were checked at least once 
in 24/29 (83%) of the remaining patients. Of the five 
patients who did not have postoperative bloods checked, 
one was at high risk but did not have the score done.
Two of the patients developed AKI postoperatively; 
both would have been classified as high risk of AKI preop-
eratively though the score was not completed in one of 
the patients.
lessons and limiTaTions
One of the strengths of our project is that it is generalis-
able to other hospitals. The score we used has been exter-
nally validated for use in patients undergoing orthopaedic 
surgery. We involved the key stakeholders from the begin-
ning of our project and had strong support from both the 
anaesthetic and orthopaedic teams.
A limitation of this study was the small numbers of 
patients in the first and second PDSA cycles. This was in 
part because some of the data we collected were from 
patients not affected by our intervention so were excluded 
from our analysis. The data were collected by an FY2 
working in the orthopaedic department. We limited bias 
by selecting certain days to collect the data and reviewing 
the notes of all patients discharged that day. As the score 
was completed on admission this gave us a spread of 
admission days to assess and limited the effect one or two 
individuals may have had.
We anticipated that the ASA grade would be new to many 
of the staff completing the score. We therefore included 
additional information within our scoring tool. Accuracy 
with the score improved as experience increased.
We introduced the score simultaneously for elec-
tive patients and emergency patients. Although the 
score is being used well for elective patients it remains 
Figure 1 Compliance with using AKI risk score over four 
PDSA cycles. AKI, acute kidney injury.
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disappointingly low for emergency patients. This is, in 
part, driven by very low rates of score completion for 
patients undergoing upper limb or foot surgery. In retro-
spect, a two-stage approach, implementing our project 
for elective patients first followed by emergency patients 
later, may have allowed us to target our interventions with 
greater effect.
There was still relatively poor fluid balance monitoring 
of orthopaedic patients postoperatively. As this applies to 
all patients, not just those at high risk, it may be that this 
is better taken forward as a separate quality improvement 
project.
conclusion
We introduced a preoperative scoring tool that predicts a 
patient’s risk of postoperative AKI into the assessment of 
patients undergoing orthopaedic surgery that require an 
overnight stay. Use of the score was good among patients 
undergoing elective surgery but remained significantly 
below our target for patients admitted for emergency 
procedures.
We were able to demonstrate that our electronic scoring 
tool was reliable and could be used accurately. There 
was excellent compliance with medication adjustments 
and postoperative renal function monitoring in patients 
found to be at high risk of AKI, but postoperative fluid 
balance monitoring was still relatively poor.
There will be a rolling audit in the department that will 
aim to further improve compliance with using the score. 
We also plan to implement our scoring tool into the 
orthopaedic departments at the other hospitals within 
NHS Tayside.
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